The Journal of Emergency Medicine
Volume 41, Issue 5 , Pages 524-530 , November 2011

The Value of Procalcitonin, a Novel Inflammatory Marker, in the Diagnosis of Myocardial Infarction and Evaluation of Acute Coronary Syndrome Patients

  • Firat Bektas, MD

      Affiliations

    • Department of Emergency Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey
    • Corresponding Author InformationReprint Address: Firat Bektas, md, Department of Emergency Medicine, Akdeniz University Faculty of Medicine, Antalya 07059, Turkey
    • ,
  • Secgin Soyuncu, MD

      Affiliations

    • Department of Emergency Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey
    • ,
  • Ilker Gunduz, MD

      Affiliations

    • Department of Emergency Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey
    • ,
  • Ibrahim Basarici, MD

      Affiliations

    • Department of Cardiology, Akdeniz University Faculty of Medicine, Antalya, Turkey
    • ,
  • Halide Akbas, MD

      Affiliations

    • Department of Biochemistry, Akdeniz University Faculty of Medicine, Antalya, Turkey
    • ,
  • Cenker Eken, MD

      Affiliations

    • Department of Emergency Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey

Received 4 December 2009 ,Revised 22 February 2010 ,Accepted 19 May 2010.

References 

  1. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515–518
  2. Jacobs JW, Lund PK, Potts JT, et al. Procalcitonin is a glycoprotein. J Biol Chem. 1981;256:2803–2807
  3. Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg. 2007;245:745–754
  4. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198–1210
  5. Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 1998;24:185–188
  6. Carsin H, Assicot M, Feger F, et al. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury. Burns. 1997;23:218–224
  7. Nylen ES, Al Arifi A, Becker KL, et al. Effect of classic heatstroke on serum procalcitonin. Crit Care Med. 1997;25:1362–1365
  8. Arkader R, Troster EJ, Abellan DM, et al. Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients. J Cardiothorac Vasc Anesth. 2004;18:160–165
  9. Macrina F, Tritapepe L, Pompei F, et al. Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery. Perfusion. 2005;20:169–175
  10. Visvardis G, Griveas I, Fleva A, et al. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients. Ren Fail. 2005;27:429–434
  11. Buratti T, Ricevuti G, Pechlaner C, et al. Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation. 2001;25:97–100
  12. Remskar M, Horvat M, Hojker S, et al. Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr. 2002;114:205–210
  13. Ilhan F, Akbulut H, Karaca I, et al. Procalcitonin, C-reactive protein and neopterin levels in patients with coronary atherosclerosis. Acta Cardiol. 2005;60:361–365
  14. Senturk T, Cordan J, Baran I, et al. Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol. 2007;62:135–141
  15. Kafkas N, Venetsanou K, Patsilinakos S, et al. Procalcitonin in acute myocardial infarction. Acute Card Care. 2008;10:30–36
  16. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation. 2000;102:2031–2037
  17. Antman EM, Hand M, Armstrong PW, et al. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee. Circulation. 2008;117:296–329
  18. Pollack CV, Braunwald E. 2007 Update to the ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: implications for emergency department practice. Ann Emerg Med. 2008;51:591–606
  19. Immunochromatografic test for the determination of PCT (procalcitonin) in human serum and plasma. Available at: http://www.procalcitonin.com/pdf/PCT-Q/10602R10.pdf. Accessed August 19, 2010.
  20. Kip KE, Hollabaugh K, Marroquin OC, et al. The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention. J Am Coll Cardiol. 2008;51:701–707
  21. Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34:1996–2003
  22. Jones AE, Fiechtl JF, Brown MD, et al. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med. 2007;50:34–41
  23. Brunetti ND, Troccoli R, Correale M, et al. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol. 2006;109:248–256
  24. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–369
  25. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103:1813–1818
  26. Clearfield MB. C-reactive protein: a new risk assessment tool for cardiovascular disease. J Am Osteopath Assoc. 2005;105:409–416

 This study was supported by Akdeniz University Research Foundation.

PII: S0736-4679(10)00522-6

doi: 10.1016/j.jemermed.2010.05.073

The Journal of Emergency Medicine
Volume 41, Issue 5 , Pages 524-530 , November 2011

Article Tools

* Image Usage & Resolution